Clinical studies of Charité
On this page, current and planned clinical studies are presented by scientists of Charité, who would like to present them on the Internet.
If you are interested in participating in one of the presented clinical studies, you can contact the corresponding clinic. The clinic will be displayed on the detail page after selecting the study.
You are here:
Filter results
Quality of life in patients with short bowel syndrome treated without and with teduglutide – a prospective nested matched- pair analysis
Short title: QoL in IF patients
Investigated disease: Kurzdarmsyndrom
Principal Investigator: Dr. med. Elisabeth Blüthner
Patient (diseased)
Age: 18 - 100
Gender: All
Status: Participants wanted
A randomized, treatment open-label, dose-blinded parallel group, three arm, proof-of-concept clinical trial to investigate the efficacy and safety of LNP023 compared with rituximab in the treatment of subjects with idiopathic membranous nephropathy
Short title: LNP023 & membr. GN
Investigated disease: membranöse GN
Principal Investigator: PD Dr. Adrian Schreiber
Patient (diseased)
Age: 18 - 99
Gender: All
An adaptive seamless randomized, double-blind, placebo-controlled, dose ranging study to investigate the efficacy and safety of LNP023 in primary IgA nephropathy patients
Short title: LNP023 & IgANP
Investigated disease: Iga Nephropathy
Principal Investigator: PD Dr. Adrian Schreiber
Patient (diseased)
Age: 18 - 99
Gender: All
Status: Participants wanted
Eine Studie der Phase II zur Beurteilung von präoperativen Kombinationsstrategien für die Immuntherapie bei Patientinnen mit unbehandeltem, operablem ER-positivem, HER2-negativem primärem Mammakarzinom
Short title: Quenn Mary Eclipse
Investigated disease: Hormonrezeptor positives primäres Mammakarzinom
Principal Investigator: Prof. Dr. Jens-Uwe Blohmer
Patient (diseased)
Age: 18 - 99
Gender: Female
Status: Participants wanted
REMAP-CAP
Short title: REMAP-CAP
Investigated disease: Pneumonia ICU
Principal Investigator: Dr. med. Andre Finn
Patient (diseased)
Age: 18 - 99
Gender: All
Status: Participants wanted
A Phase 2/3, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Protocol to Evaluate the Efficacy and Safety of Guselkumab in Participants with Moderately to Severely Active Crohn's Disease
Short title: GALAXI
Investigated disease: Morbus Crohn
Principal Investigator: Dr. med. Anja Schirbel
Patient (diseased)
Age: 18 - 80
Gender: All
Status: Participants wanted
Liberale Transfusionsstrategie zur Prävention von Sterblichkeit und Anämie-assoziierten, ischämischen Ereignissen bei älteren, nicht-herzchirurgischen Patienten
Short title: LIBERAL-Trial
Investigated disease: perioperative anaemia
Principal Investigator: Prof. Dr. Sascha Treskatsch
Patient (diseased)
Age: 18 - 99
Gender: All
Status: Participants wanted
The role of pre-formed alloreactive T cells on acute rejection episodes and long-term graft outcome in patients after living donor renal transplantation
Short title: ALLO
Investigated disease: The role of pre-formed alloreactive T cells
Principal Investigator: Prof. Dr. Klemens Budde
Patient (diseased)
Age: 18 - 99
Gender: All
Status: Participants wanted
Morbus Farby neue Therapien
Short title: Migalastat Beob. Stu
Investigated disease: Morbus Fabry
Principal Investigator: Dr. Sima Canaan-Kühl
Patient (diseased)
Age: 18 - 99
Gender: All
Status: Participants wanted
Einfluss eines Probiotikums auf den Blutdruck von Patienten mit Hypertonie Grad 1 - eine randomisierte klinische Studie (HYPRO)
Short title: HYPRO
Investigated disease: Essentielle Hypertonie Grad 1 (>140/90 mmHg)
Principal Investigator: Dr. med. Michael Boschmann
Patient (diseased)
Age: 50 - 75
Gender: All